The glycosylated env gene precursor (Pr8Oenv) of Moloney murine leukemia virus has been isolated by selective immunoprecipitation. Use of the drug tunicamycin to inhibit nascent glycosylation or specific cleavage with endoglycosidase H demonstrated that the precursor contained an apoprotein with a molecular weight of 60,000. The finished virion glycoprotein (gp7O) was largely resistant to the action of endoglycosidase H. Chromatography of the glycopeptides of Pr8Oenu in conjunction with endoglycosidase H digestion studies suggested that the precursor contained two distinct major glycosylation sites. Analysis of partial proteolytic cleavage fragments of Pr8Oenv before and after endoglycosidase H treatment placed the two glycosylation sites within a 30,000-dalton region of the apoprotein sequence. Kinetic experiments showed that carbohydrate processing as well as proteolytic cleavage are late steps in the maturation of Pr8Oenv. Genome mapping correlated with in vitro translation studies has shown that a 20 to 22S mRNA encoded from the 3' third of the murine leukemia virus (MuLV) genome is translated in vivo into a glycosylated polyprotein with a molecular weight of 80,000 to 90,000 designated Prenv (4, 22, 34) . Prenv is synthesized and processed in cellular membranes by proteolysis and carbohydrate alteration to the finished env gene products gp70 and pi5E (5, 13, 16, 18, 26, 37) .
Recent work on other viral and cellular glycoprotein systems has shown that the primary glycosylation event involves the en bloc transfer of a large, branched, preformed, lipid-linked, high-mannose-containing structure to the polypeptide chain. This glycosylation can occur on nascent polypeptide chains. Subsequently, these core or high-mannose groups are processed in the rough and smooth endoplasmic reticulum by initial cleavage followed by sequential additions of sugars including fucose and terminal sialic acid into distinct branched-chain patterns referred to as complex carbohydrate groups (7, 8, 19, 20, 29, 35) .
The elucidation of the carbohydrate structures of Pren' and gp7O, and of the relationship of carbohydrate processing and proteolytic cleavage to the viral budding event, is a central concern of these studies. We have examined the structure of the MuLV glycoprotein precursor (Pren"), using the drug tunicamycin (30, 35) , which inhibits forrmation of the high-mannose carbohydrate groups, and the enzyme endoglycosidase H (endo H) (31) , which cleaves en bloc these high-mannose groups from the polypeptide backbone. Our results indicate that the carbohydrate processing of the MuLV Prenv is similar to that described for other animal viral systems (8, 20) . In addition, these carbohydrate groups provide a useful marker in studying the structure of the env gene precursor and its products.
MATERIALS AND METHODS
CeUs and viruses. Wild-type Moloney MuLV, temperature-sensitive Moloney ts3 (38) , and Rauscher ts24 (27) strains were all cloned and grown in NIH/3T3 cells as previously described (36 (11, 37) . Sera used included rabbit anti-Moloney gp7O, rabbit anti-Moloney p30, and rabbit anti-Moloney virions previously characterized (36) . Washed precipitates were denatured in 1% SDS-1% 2-mercaptoethanol and subjected to electrophoresis on a discontinuous stack, Tris-buffered polyacrylamide gel system as previously describ3d (12, 37) . Gels were fluorographed by the procedure of Bonnar and Laskey (1) . Standard proteins used as molecularweight markers included rabbit immunoglobulin heavy (50,000) and light (25,000) chains, MuLV p30 (30,000) and p12 (12, 000) , and the structural proteins of vesicular stomatitis virus and adenovirus type 2. Enzyme digestions: endo H digestion. Endo 1-N-acetylglucosaminidase H was prepared by the method described by Tarentino and Maley (31 
RESULTS
Size of the Prenv apoprotein. Previous studies using 2-deoxyglucose, glucosamine, or cytochalasin to inhibit glycosylation in Rauscher leukemia virus-infected cells demonstrated an apparent molecular weight shift from 90,000 to 70,000 for the glycosylated and nonglycosylated forms of Pren", respectively (26, 32) . To confirm and extend this observation, we used the drug tunicamycin, an inhibitor of glycosylation known to act at the first step of glycoprotein carbohydrate addition. Tunicamycin inhibits the formation of a lipid-linked, high-mannose core structure added en bloc to polypeptide chains (14, 19, 28, 30, 35) .
When cells infected with Moloney MuLV were treated with tunicamycin, there was a shift in the apparent molecular weight of Prenv ( (Pr8Oenv) to 60,000 (P60e"v). This result indicated that a significant fraction of the primary glycosylation of Pr8Oenu occurred by transfer of tunicamycin-sensitive, lipid-linked, high-mannose structures similar to that described for several other animal viruses (7, 8, 20) . The size of the core precursor (Pr65505) and its cleavage products was unaffected (Fig. 1A , B and C, lane 2). A significant decrease in the rate of protein synthesis was observed ( Fig. 1B and C) with high doses of this tunicamycin preparation.
As an alternative method for removing carbohydrate from Prenv, we used the enzyme endo (Fig. 2A , + lane), the Pr8Oenv had an increased electrophoretic mobility (designated P60"). Determinations of glycoprotein molecular weight by SDS electrophoresis are generally overestimates (24) . The shift of molecular weight from Pr8Oenv to p60env does not indicate that 20,000 daltons of carbohydrate was removed, but only that the carbohydrate groups added to an apoprotein with a molecular weight of 60,000 cause it to move at an apparent molecular weight of 80,000 in SDS-gels. Digestion with endo H had no effect on the size of the Pr65`9 precursor or its cleavage products immunoprecipitated with anti-p30 serum. If the Pr8Oe`v was labeled with [3H]mannose, however, all of the [3H]mannose label was removed from the protein (data not shown).
When cells infected with other strains of MuLV were treated in the same manner, a similar increase in electrophoretic mobility of Prenv was observed. Moloney ts3 Pr80env was shifted to p60env (Fig. 2B) , and Rauscher ts24 Pr90env was shifted to P70"l ( Fig. 2C) The glycopeptides derived from virion gp7O resolved into several components as shown in Fig. 4C . Endo H digestion of the gp70 glycopeptides indicated that most of the glycopeptides were resistant to cleavage by endo H (Fig. 4D) . This was in contrast to the glycopeptides derived from the Pr80env, which were sensitive to the action of endo H. A fraction of the gp70 glycopeptides (15 to 20%) were sensitive to cleavage by endo H. This is similar to the Sindbis virus glycoprotein complex, which contains a partially processed high-mannose group susceptible to endo H cleavage in the finished virion (2, 20 (Fig. 6, panel A) with S. aureus V8 protease (5.0 utg/ml) in 0.5% SDS and then was analyzed on SDS-10% acrylamide gels. These conditions generated fairly large fragments with molecular weights from 70,000 to 27,000. Pr8Oenv labeled with [2-3H]mannose was similarly treated (Fig. 6, panel B) . The fragment with a molecular weight of 27,000 was deficient in carbohydrate label, showing that both sugar side chains are confined to a region less than or equal to one-half of the apoprotein length.
As an alternative to [3H]mannose labeling, we used endo H to identify sugar-containing fragments. Pr8Oenv labeled with [35S]methionine was first digested with a pretitered amount of protease. The proteolysis was stopped by boiling the reaction mixture, and one-half was subsequently digested with endo H.
Pr8Oenv control, not treated with any protease, is shown in Fig. 7A (-lane) . Treatment with endo H (+ lane) shifted the apparent molecular weight to P60en'. A minor component precipitated with anti-gp7O serum with a molecular weight of approximately 50,000 was also sensitive to treatment with endo H. This may have represented a precursor form for the minor glycoprotein gp45 described for MuLV and shown to overlap with the amino-terminal end of gp7O in its primary structure (6) .
Digestion with S. aureus V8 protease (5.0 ,ug/ml) (Fig. 7B) for 10 or 40 min generated fragments from full length (80,000) to material -10,000 migrating at the buffer front. Subsequent treatment with endo H (+ lanes) shifted many, but not all, fragments to lower molecular weight. These fragments presumably contained at least one high-mannose group sensitive to 30 ,000) supported the placement of both glycosylation sites in one-half of the apoprotein sequence. Although both gp70 and pl5E portions of Pr8Oenv (10, 33) contain methionine residues, some smaller fragments lacking methionine could have been missed by this analysis. Continued digestion with S. aureus V8 protease or several other very active proteases, including
Pronase, eventually degraded all of Pr8Oenv to material less than 10,000 in molecular weight (data not shown).
In contrast to this pattern, digestion with high concentrations of a-chymotrypsin (10 ,ug/ml) (Fig. 7C) or thermolysin (15 ,ug/ml) (Fig. 7D) revealed some fragments relatively resistant to further proteolytic cleavage. Both enzymes yielded similarly sized but not identical doublets with molecular weights of approximately 20,000. Both components of these doublets shifted to lower apparent molecular weight by about 6,000 to 8,000 (estimated molecular weight) after treatment with endo H (+ lanes). A similar pattern was observed with trypsin digestion (data not shown). The different amino acid specificities of thermolysin, a-chymotrypsin, and trypsin, and their relative, not absolute, resistance make it unlikely that these fragments originated as a result of some peculiar primary structure. Partial digestion studies with endo H suggested that each protease-resistant fragment contained a single high-mannose group (data not shown).
Bulky carbohydrate side chains appear to provide specific protection against proteolysis in vivo for many glycoproteins (17) . Removal of carbohydrate could reveal new sites for proteolytic cleavage in vitro as well. Pr8Oenv was first digested with endo H, and the resultant P60env was used as substrate for partial proteolytic cleavage with S. aureus V8 protease (Fig. 8) . A 
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' It (37) , combined with pulse-chase data of Fig. 5 , suggests that carbohydrate modification and proteolytic cleavage are both late events in the intracellular processing.
The precise position of the high-mannose carbohydrate additions along the apoprotein sequence is not known. However, several constraints on the structure of Pren" can be deduced from the peptide fragment data of Fig. 6, 7 , and 8. Glycosylated fragments with molecular _-; ; weights of 45,000 to 50,000 which shift to 30,000 to 35,000 after endo H treatment ( Fig. 7 and 8 After protease digestion, samples were boiled and one-half was subsequently digested (+) with endo H (3 pg/ml) for 1 h at 30°C. Fragments were analyzed on a SDS-10%polyacrylamide gel developed by fluorography. Panels A and B were exposed for 3 days; panels C and D, for 1 day.
shift to lower molecular weight for the deglycosylated fragments of p60env was seen (Fig. 8D ) when compared to those generated from Pr8Oenv (Fig. 8B) 27,000 and lacks mannose label (Fig. 6 ) demonstrate that both sugar groups are confined to a region of one-half the apoprotein length.
The reported orientation of NH2gp7O-pl5E-COOH for Prenv and lack of carbohydrate on pl5E (5, 9, 10, 15, 33) would limit the carbohydrate sites to an N-terminal molecular-weight region of 45,000, within the gp7O sequence. If the naturally occurring fragment with a molecular weight of 50,000 to 55,000 cross-reactive with gp7O which shifts to a molecular weight of 35,000 after endo H treatment (Fig. 7) does represent a precursor form to gp45, then a further constraint on the structure of Pren" can be noted. Since gp45 and gp7O share the same aminoterminal sequence (6) , this fragment would place the glycosylation sites within the amino one-half of the apoprotein sequence. Further work is necessary to confirm this working hypothesis.
The two protease-resistant endo H-sensitive fragments with molecular weights of 15,000 to 20,000 (Fig. 7) suggest that each high-mannose group may protect a peptide region of 12,000 to 15,000 in molecular weight. This relative protection may result from an actual structural block of the proteolytic sites by the carbohydrate or alternately could reflect a secondary structure of the peptide region surrounding the carbohydrate.
Detailed knowledge of the primary structure of the MuLV env gene precursor and its intracellular processing will require further analysis. In particular, the precise relationship of the conservation of peptide sequences in Pr8OenU to the virions gp7O and pl5E is unknown. Peptide mapping with uniformly labeled protein or primary sequence data will be necessary to approach such questions. The ability to prepare deglycosylated (tunicamycin-treated) or poorly glycosylated (endo H-treated) env gene apoprotein and its fragments should be useful in this regard.
